Guardant Health: Look For Explosive Revenue Growth Ahead [Seeking Alpha]
Guardant Health, Inc. (GH)
Last guardant health, inc. earnings: 2/24 04:03 pm
Check Earnings Report
Company Research
Source: Seeking Alpha
GH's Shield is the first FDA-approved blood test for primary colorectal cancer screening, with rapid early adoption and significant pricing power due to ADLT status. GH's integrated platform, product breadth, and first-mover advantage in blood-based CRC screening position it to take share from Natera and expand into new markets. Strong cash runway, improving margins, and accelerating revenue ramp suggest GH could become cash flow positive by end of 2027, supporting a bullish outlook. MoMo Productions/DigitalVision via Getty Images Guardant Health, Inc. ( GH ) was founded in 2012 and is based in Palo Alto, CA. It describes itself as a "precision oncology company focused on guarding wellness and giving every person more time free from cancer." The This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the pur
Show less
Read more
Impact Snapshot
Event Time:
GH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GH alerts
High impacting Guardant Health, Inc. news events
Weekly update
A roundup of the hottest topics
GH
News
- Guardant Health (NASDAQ:GH) had its "buy" rating reaffirmed by analysts at UBS Group AG.MarketBeat
- Guardant Health to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026Business Wire
- Alger Small Cap Focus Fund Q4 2025 Portfolio Update [Seeking Alpha]Seeking Alpha
- Guardant Health (NASDAQ:GH) had its "buy" rating reaffirmed by analysts at Guggenheim.MarketBeat
- Omics Lab Services: Global Market Review 2021-2025 and Forecast 2026-2031 Featuring Profiles of Agilent Technologies, Q2 Solutions, Flomics Biotech, QIAGEN, Thermo Fisher Scientific and More [Yahoo! Finance]Yahoo! Finance
GH
Earnings
- 10/29/25 - Beat
GH
Sec Filings
- 1/22/26 - Form 4
- 1/22/26 - Form 4
- 1/22/26 - Form 5
- GH's page on the SEC website